• Exchange: Frankfurt
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Specialty Pharma

Pluristem Therapeutics Inc

+ Add to Watchlist

PJTA:GR

1.990 EUR 0.058 2.83%

As of 15:16:52 ET on 12/23/2014.

Snapshot for Pluristem Therapeutics Inc (PJTA)

Open: 2.001 Day's Range: 1.990 - 2.060 Volume: 0
Previous Close: 2.048 52wk Range: 1.898 - 3.595 1-Yr Rtn: -15.61%

Stock Chart for PJTA

No chart data available.
  • PJTA:GR 2.023
  • 1D
  • 1M
  • 1Y
2.048
Interactive PJTA Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for PJTA

Current P/E Ratio (ttm) -
Estimated P/E(06/2015) -
Relative P/E vs. DAX -
Earnings Per Share (USD) (ttm) -
Est. EPS (USD) (06/2015) -0.3570
Est. PEG Ratio -
Market Cap (M EUR) 139.79
Shares Outstanding (M) 70.24
30 Day Average Volume 217
Price/Book (mrq) -
Price/Sale (ttm) -
Dividend Indicated Gross Yield -%
Cash Dividend -
Dividend Ex-Date
5 Year Dividend Growth -
Next Earnings Announcement 02/05/2015
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for PJTA

  • Revenue
  • Net Income (M/USD)
  • Profit Margin (%)

Company Profile & Key Executives for PJTA

Pluristem Therapeutics, Inc. develops Messenchymal stem cell production technology and commercializes cell therapy products. The Company focuses on cell therapy to treat severe blood, cardiovascular, autoimmune, and other disorders.

Zami AbermanChief Executive OfficerYaky YanayPresident/COO
Boaz Gur-LavieCFO/Secretary
More Company Profile & Key Executives for PJTA

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil